Diagnostic Co.'s Oversight Reforms Deal Gets Final OK
A California federal judge has given final approval to a deal ending shareholder derivative claims that diagnostics company CareDx's executives and directors damaged the company by concealing its scheme to inflate...To view the full article, register now.
Already a subscriber? Click here to view full article